文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?

作者信息

Lau Harry Cheuk-Hay, Ng Siew C, Yu Jun

机构信息

Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.

Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, Center for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China; Microbiota I-Center (MagIC), Hong Kong SAR, China.

出版信息

Gastroenterology. 2022 Jan;162(1):9-16. doi: 10.1053/j.gastro.2021.09.009. Epub 2021 Sep 8.

DOI:10.1053/j.gastro.2021.09.009
PMID:34508775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8425294/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e4/8425294/5f8c4276a33c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e4/8425294/5f8c4276a33c/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e4/8425294/5f8c4276a33c/gr1_lrg.jpg

相似文献

[1]
Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?

Gastroenterology. 2022-1

[2]
Crosstalk between COVID-19 and the gut-brain axis: a gut feeling.

Postgrad Med J. 2024-7-18

[3]
Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut Microbiota Dysbiosis: Study Protocol for a Randomized Controlled Trial.

Curr Med Sci. 2021-12

[4]
Microbiota Modulation of the Gut-Lung Axis in COVID-19.

Front Immunol. 2021

[5]
Role of Probiotics in the Management of COVID-19: A Computational Perspective.

Nutrients. 2022-1-10

[6]
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.

World J Gastroenterol. 2022-12-21

[7]
From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.

Mediators Inflamm. 2021

[8]
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.

Gut Microbes. 2022

[9]
The impact of probiotics on interactions within the microbiota-gut-lung triad in COVID-19.

Int J Food Sci Nutr. 2021-6

[10]
Probiotics and Coronavirus disease 2019: think about the link.

Br J Nutr. 2021-11-28

引用本文的文献

[1]
Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome.

mSystems. 2024-10-22

[2]
A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.

Nutrients. 2024-5-21

[3]
Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions.

MedComm (2020). 2024-3-15

[4]
Impact of SARS-CoV2 infection on gut microbiota dysbiosis.

Microbiome Res Rep. 2023-12-6

[5]
Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19.

Genes Dis. 2023-6-19

[6]
Functional Foods: A Promising Strategy for Restoring Gut Microbiota Diversity Impacted by SARS-CoV-2 Variants.

Nutrients. 2023-6-5

[7]
Gut microbiota and synbiotic foods: Unveiling the relationship in COVID-19 perspective.

Food Sci Nutr. 2023-1-11

[8]
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.

Viruses. 2023-1-31

[9]
Ongoing Treatment with a Spore-Based Probiotic Containing Five Strains of Improves Outcomes of Mild COVID-19.

Nutrients. 2023-1-17

[10]
Dynamic changes in host immune system and gut microbiota are associated with the production of SARS-CoV-2 antibodies.

Gut. 2023-10

本文引用的文献

[1]
Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.

Inflamm Bowel Dis. 2022-2-1

[2]
COVID vaccine boosters: the most important questions.

Nature. 2021-8

[3]
Rapid resolution of COVID-19 after faecal microbiota transplantation.

Gut. 2022-1

[4]
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19.

Gut. 2021-7

[5]
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.

Gastroenterology. 2021-6

[6]
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.

Gut. 2021-4

[7]
Human recombinant soluble ACE2 in severe COVID-19.

Lancet Respir Med. 2020-11

[8]
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.

Gastroenterology. 2021-1

[9]
Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.

Clin Infect Dis. 2021-5-18

[10]
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.

Gut. 2021-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索